Live News

Medical and Health
FDA Drugs 耐药性
FDA Updates on Bebtelovimab
FDA is providing updates on the effectiveness of bebtelovimab as a COVID-19 therapeutic option against certain subvariants...
FDA Announces Bebtelovimab is Not Currently Authorized in Any US Region
FDA Announces Bebtelovimab is Not Currently Authorized in Any US Region due to the rise in SARS-CoV-2 variants that it is ...
Prolia (denosumab) by Amgen: Drug Safety Communication - FDA Investigating Risk of Severe Hypocalcemia in Patients on Dialysis
FDA is investigating the risk of severe hypocalcemia with serious outcomes, including hospitalization and death, in patien...
FDA’s Labeling Resources for Human Prescription Drugs - 01/26/2023
Webinar to discuss new FDA labeling resources for human prescription drugs.
Newhere Inc dba CBDFX - 629243 - 11/16/2022
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products
Infusionz, LLC - 629248 - 11/16/2022
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products
11-11-11 Brands - 627690 - 11/16/2022
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products